FDA Pulls Unapproved Cough Medications From Shelves

The Food & Drug Administration (FDA) has made it is duty to remove all unapproved cough syrups that contain hydrocodone. The FDA will put the focus on the manufacturers of the products and enforce that they stop production of them. This move by the FDA is there step up to fight against drugs that have not been approved by them.

The Hydrocodone is found in many of these cough syrups is a very powerful drug, which is often prescribed as pain medication or used in cough suppressants. Statistics presented by the FDA shows that hydrocodone is an active ingredient in over 200 prescription cough medications. With this high number of products available, only a small amount has been approved for use by the agency.

Hydrocodone is very addictive drug and abuse of the this product has caused injury and even death. Many people who take this medication and have an overdose, often will have problems breathing and there is the possibility of a heart attack.

The FDA has indicated that many of the unapproved cough medications that contain hydrocodone do not have the proper labels on them. They are also said to be very similar to their approved counterparts. Another concern that the FDA has regarding the use of these cough suppressants is the labeling and children. The FDA has not authorized the use of hydrocodone in products that were intended for children who were under the age of two. The unapproved cough suppressants that contain the drug are often labeled as being appropriate for young children.

The FDA gave orders to these companies that were making the unapproved cough suppressants specific bid to stop manufacturing and distribution of these products. This had a far reaching effect, especially to those companies who were marketing their product to young children.

This move by the FDA is a new effort by the agency to put a stop to those companies that are marketing these products that contain unapproved prescription drugs in them.

Leave a Reply